See: https://www.fda.gov/consumers/consumer-updates/coronavirus-d...
I don't know the answer to your question, but it would make sense unless the antibody test(s) look for a specific type of antibody to COVID-19 that is produced naturally when infected and not just any antibodies that might be produced when vaccinated.
As the disease becomes less common, it makes sense to turn down the sensitivity of the test. Base rate fallacy, yada yada.
https://academic.oup.com/cid/advance-article/doi/10.1093/cid...
(image from the study) https://i.imgur.com/AaZZIXM.png
You're also putting a whole lot of weight on a study with what, about 50 total positives? And of them, very few with a Ct of over 35.
here's one I found with a quick google (haven't read the study)
High sensitivity was very worthwhile early in the pandemic, when infection was common and the predictive value of a test with a somewhat higher false positive rate was still high. Now that COVID is becoming rarer, we should absolutely be reducing cycle counts. The target should be to keep >75% of positives with actual infection even as the underlying rate of the disease decreases. I think we've exceeded this threshold by a large margin thus far. If you have a cogent statistical argument that disagrees instead of handwaving about cycle counts, I'm willing to listen.
All of those numbers are below 40ct - if this doesn't convince you that 40ct is the wrong number I don't know what to say - you've provided zero evidence that 40ct is beneficial and try to downplay extremely high false positives shown in three studies when you go to 40ct
It's a sensitivity vs. specificity issue, as I've said before, and I'm willing to listen to arguments on those grounds.
As the studies you've cited show, the vast majority of positive samples become so before 30 cycles. Then there's these relatively few "weak positive" results, where the ability to culture live virus is less. There's not enough of these to explain the number of cases, deaths, or overall excess mortality (as you've attempted to say elsewhere here, and others have rightfully corrected you). And these results being considered a positive is arguably a good thing while the virus is very common, as I've attempted to explain to you.
> 2nd study shows 34ct is the cutoff for infectivity and that 2nd study also cites a 3rd study that ct>35 decreased to 8% active viruses
Yes, but "infective at the moment you took the test" is not a useful metric. You want more people to be positive than this, so you can A) contact trace people who were infectious immediately before, and B) get people who were just infected to stay home -before- they're infectious.
Of course, now that we're on a major downslope of cases, this tradeoff is changing...
- Zero naturally-occurring antibodies (the kind you would get from having had COVID).
- Strong presence of vaccine-induced antibodies.
However, given the timing, I am still uncertain as to whether I contracted COVID during that post-second-jab 4 weeks when my girlfriend was infected (I gave blood for the test while I was still feeling bad in the weeks after the second injection, and I didn't spring for the 'currently infected' test, since the whole package of tests was pretty expensive).
If I got COVID now, would it not be handled exclusively by vaccine-induced antibodies, which means that any test for having had COVID in the future would still be negative?
I'm no kind of doubter, and I'm pretty sure the AZ double-jab helped me lately, but I'm not sure I'll ever know if I was ever infected, to be honest.
I hope you better half fully recovered by now.
there are several antibody tests for covid. As far as I'm aware, the vaccines only trigger the anti-spike protein antibodies, so if you test positive for other types of covid-19 antibodies, you've probably had it.
However, all currently used vaccines are just the spike (S) protein plus possible non-COVID proteins (in the viral vector vaccines), so none will induce antibodies against the COVID N protein.
I imagine it might be possible to guess whether someone was vaccinated with the AZ vaccine based on whether they have antibodies that are specific to the site that’s modified in the stabilized sequences. I don’t think anyone does a test like that.